In late 2019, SARS-CoV-2, a new coronavirus causing COVID-19, emerged in Wuhan (China). As of April 13 2020 it has caused 1.807.308 infections and 119.410 deaths worldwide. Due to the way this virus is transmitted and considering gastroenterology and digestive endoscopy services are a source of easy dissemination given the constant exposure with aerosols that are emitted during procedures there is an increased risk for both health care professionals and patients undergoing endoscopy. It is of great importance to establish prevention tools within the gastroenterology and digestive endoscopy services, based on the evidence gathered to date and recognizing that we are in a constant search for measures to reduce risk of infection that will provide a safe environment to staff and patients. Pubmed database was searched for the following terms: (“COVID-19” OR “coronavirus” OR “SARS-Cov-2”) and (“gastrointestinal” OR “transmission” OR “intestinal” OR “digestive” OR “endoscopy” OR “esophagogastroduodenoscopy” OR “colonoscopy”). Therefore, all patients brought in to undergo endoscopic procedures should be considered high-risk and current prevention tools will be made known worldwide.